Respiratory Drugs
434 FDA-approved drugs
TheraRadar tracks 434 FDA-approved respiratory drugs from 151 companies across 20 drug classes, led by GSK, with 655 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Respiratory.
Respiratory Approvals by Year
12
'15
3
'16
13
'17
6
'18
5
'19
3
'20
5
'21
5
'22
3
'23
5
'24
6
'25
3
'26
Recent Respiratory Drug Approvals
NINTEDANIB
NINTEDANIB
2026-07-09
ACCORD HLTHCARE
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE
BUDESONIDE
asthma in patients 6 years of age and older...
2026-04-23
Teva
AIR
AIR
2026-02-02
GENERAL AIR SERVICE & SUPPLY COMPANY
MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM
DEXTROMETHORPHAN HYDROBROMIDE
2025-12-22
RECKITT BENCKISER
EXDENSUR
DEPEMOKIMAB-ULAA
the add‑on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adul...
2025-12-16
GSK
IL-5
BECLOMETHASONE DIPROPIONATE
BECLOMETHASONE DIPROPIONATE
the relief of acute bronchospasm...
2025-12-16
AUROLIFE PHARMA LLC
Glucocorticoid receptor
JASCAYD
NERANDOMILAST
idiopathic pulmonary fibrosis (IPF) in adult patients...
2025-10-07
Boehringer Ingelheim
PDE4B
BRINSUPRI
BRENSOCATIB
non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older...
2025-08-12
INSMED INC
DPP1
OMLYCLO
OMALIZUMAB-IGEC
acute bronchospasm or status asthmaticus...
2025-03-07
CELLTRION INC
FcεRIIgE
ALYFTREK
DEUTIVACAFTOR
cystic fibrosis (CF) in patients 6 years of age and older who have at least one F508del mutation or ...
2024-12-20
Vertex Pharmaceuticals
CFTR
OHTUVAYRE
ENSIFENTRINE
the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients...
2024-06-26
Merck
PDE3PDE4
AZELASTINE HYDROCHLORIDE ALLERGY
AZELASTINE HYDROCHLORIDE
2024-05-29
Aurobindo Pharma
AZELASTINE HYDROCHLORIDE CHILDREN'S ALLERGY
AZELASTINE HYDROCHLORIDE
2024-05-29
Apotex
LEGUBETI
ACETYLCYSTEINE LYSINE
2024-02-13
GALEPHAR
TIOTROPIUM BROMIDE
TIOTROPIUM BROMIDE
the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive...
2023-06-20
Lupin
SYMBICORT AEROSPHERE
BUDESONIDE
2023-04-28
AstraZeneca
AIRSUPRA
ALBUTEROL SULFATE
the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations...
2023-01-10
AstraZeneca
Beta-2 adrenergic receptor
XENOVIEW
XENON XE-129 HYPERPOLARIZED
use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric...
2022-12-23
POLAREAN
NASONEX 24HR ALLERGY
MOMETASONE FUROATE
2022-03-17
PERRIGO PHARMA INTL
BREYNA
BUDESONIDE
asthma in patients 6 years of age and older...
2022-03-15
Viatris
Glucocorticoid receptorbeta 2-adrenoceptor
Showing the 20 most recent of 434 respiratory drugs. View all 434 →
Top Respiratory Companies
Respiratory Active Trials by Indication
655 active trials — the forward pipeline, not just approvals.
Asthma 185 COPD 147 Pneumonia 101 Idiopathic Pulmonary Fibrosis 89 Chronic Rhinosinusitis with Nasal Polyps 52 Cystic Fibrosis 43 Allergic Rhinitis 38
All competitive landscapes → Respiratory Drug Classes
Corticosteroid 12
Aminoglycoside Antibacterial 5
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator 3
Surfactant 3
Anti-IgE 2
Pyridone 2
Phosphodiesterase 4 Inhibitor 2
Interleukin-5 Antagonist 2
Leukotriene Receptor Antagonist 2
Phosphodiesterase 3 Inhibitor 1
Respiratory at a Glance
- Total Drugs
- 434
- Companies
- 151
- Drug Classes
- 20
- Active Trials
- 655
- Latest Approval
- 2026-07-09